Hurone AI adds Mayo Clinic's HOUSES index to cancer navigation platform

Hurone AI said it has licensed Mayo Clinic's HOUSES social determinants of health technology and is integrating it into its oncology navigation platform. The company aims to help cancer centers identify higher-risk patients earlier and deliver more personalized support around barriers like transportation, finances and nutrition.

Why it matters: - Cancer outcomes are shaped by more than treatment and biology. Hurone AI says the new integration is designed to help cancer centers identify social risk earlier and intervene before barriers derail care. - The platform targets patient support at scale, including transportation, financial assistance and nutrition access.

What happened: - Hurone AI announced it has licensed Mayo Clinic's HOUSES technology through a know-how agreement. - The agreement brings Mayo Clinic's validated socioeconomic measurement into Hurone AI's governed cancer navigation platform. - The announcement was dated June 25, 2026, from Seattle. - Hurone AI's flagship product, Hurona, is already deployed at leading academic medical centers.

The details: - HOUSES stands for HOUsing-based index of Socioeconomic Status. - The index measures individual-level socioeconomic status using housing characteristics. - Mayo Clinic has validated HOUSES to predict more than 70 health outcomes. - Hurone AI says the integration will help cancer centers stratify risk and connect patients with services that address social needs. - The platform is built to support patients from diagnosis through survivorship. - Hurone AI says the system provides real-time symptom management, treatment education, logistics coordination and escalation to clinical teams when needed. - The company says the platform is integrated into Epic electronic health record workflows. - Hurone AI says it is measuring outcomes across patient experience, clinician efficiency and healthcare utilization. - Mayo Clinic has a financial interest in the referenced technology and says any revenue will support its not-for-profit mission in patient care, education and research. - Mayo Clinic says artificial intelligence should enhance clinicians, not replace their expertise, empathy or judgment.

Between the lines: - The deal signals a push beyond measuring health disparities toward operational tools that can change care delivery inside oncology workflows. - Hurone AI is positioning social risk stratification as a clinical input, not just a reporting metric. - Mayo Clinic's financial interest means the relationship has a commercial component even as the technology is framed as equity-focused.

What's next: - Hurone AI plans to use the HOUSES integration to give cancer centers more personalized support pathways. - The company will continue tracking results as the platform expands inside clinical settings. - Hurone AI says the goal is to reduce administrative burden while improving adherence and outcomes.